Connect with us

Life Sciences

Exec Hires: Zocalo Health Appoints First-Ever Latina Chief Medical Officer

Dr. Sarah Lopez, Chief Medical Officer at Zocalo Health What You Should Know: – Zócalo Health, a Latino-founded healthcare service designed for Latino…

Published

on

This article was originally published by HIT Consultant
Exec Hires: Zocalo Health Appoints First Ever Latina Chief Medical Officer
Dr. Sarah Lopez, Chief Medical Officer at Zocalo Health

What You Should Know:

 Zócalo Health, a Latino-founded healthcare service designed for Latino patients, has announced today the appointment of Dr. Sarah Lopez as its Chief Medical Officer making her the first-ever Latina CMO.

– As Chief Medical Officer, Dr. Lopez will lead the expansion of Zócalo’s care model, growth of their clinical team, and the development of the company’s culturally aligned services.

Dr. Lopez Bio/Background

Prior to joining Zócalo Health, Dr. Lopez practiced Emergency Medicine at LAC+USC, one of the nation’s top EM training programs. Dr. Lopez currently sits on the board of local California non-profits where she actively works to build trust between healthcare institutions and the community. Lopez received her medical degree at the University of California, Irvine where she was part of UCI’s first Program In Medical Education for the Latino Community (PRIME-LC) cohort, a program focused on training highly qualified doctors who are culturally competent and dedicated to serving the diverse population of Southern California.

cmo

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending